유유제약2우B

000227KOSPI

58.0 / 100

Reference Date: 2026-04-13

Financial Score25.5 / 40

News Sentiment12.5 / 25

Momentum10.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Revenue metrics are weak. Roughly flat over the past month, with no recent news.

Score Calculation Basis

Detailed Financial Score

PER

22.03Industry Average 15.003.0Point

Higher than industry avg (caution)

PBR

0.03Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

6.62Industry Average 8.002.5Point

Below industry avg

Debt Ratio

5.50Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20255.0 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲1.4% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲1551.5% (2-year basis)

ROE Trend

1.0 / 4

Avg ROE 3.4% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position5.0Point

52w mid range (40%)

Current 10,840Won52-week high 12,30052-week low 9,840

1-month return3.0Point

1m 0.46% (flat)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0